Elevation Oncology, Inc. (ELEV) Financials
ELEV Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 89.1 million | 34.3 million |
2023-09-30 | 100.0 million | 37.6 million |
2023-06-30 | 110.4 million | 38.2 million |
2023-03-31 | 76.9 million | 43.1 million |
ELEV Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -12.2 million | 284000 |
2023-09-30 | -13.4 million | 843000 |
2023-06-30 | -13.8 million | 744000 |
2023-03-31 | -16.8 million | 1.5 million |
ELEV Net Income
No data available :(
ELEV Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 83.1 million | - | - |
2023-09-30 | 94.8 million | - | - |
2023-06-30 | 107.9 million | 29.8 million | - |
2023-03-31 | 73.9 million | 29.6 million | - |
ELEV Shares Outstanding
ELEV Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 4.7 million | 3.3 million | 10000 |
2023-09-30 | - | 7.4 million | 3.5 million | - |
2023-06-30 | - | 6.0 million | 3.8 million | - |
2023-03-31 | - | 7.3 million | 4.3 million | - |
ELEV Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 10000 |
2023-09-30 | - | 9000 |
2023-06-30 | - | 10000 |
2023-03-31 | - | 10000 |
ELEV
Price: $4
52 week price:
Earnings Per Share: -1.34 USD
P/E Ratio: -1.43
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 9000
Market Capitalization: 230.1 million